NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: Add-on maintenance treatment of patients with severe asthma aged 6 years and older, and with an eosinophilic phenotype.
NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: The treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).
NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: The treatment of adult and pediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) for ?6 months without an identifiable non hematologic secondary cause.
Requires Refrigeration
Manufacturer # 00173089242
Brand NUCALA®
Manufacturer Glaxo Specialty
Country of Origin Unknown
Application Interleukin-5 (IL-5)
Container Type Prefilled Syringe
Dosage Form Injection
Generic Drug Name Mepolizumab
Is_Active_Vendor Y
Is_DSCSA N
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag N
NDC Number 00173089242
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Storage Requirements Requires Refrigeration
Strength 100 mg / mL
Supplier_ID 488095
Type Subcutaneous
UNSPSC Code 51202400
Volume 1 mL
